1,071 results on '"Fujihara K"'
Search Results
2. Treatment of MOG antibody associated disorders: results of an international survey
3. Role of fatty liver in the association between obesity and reduced hepatic insulin clearance
4. Attack adjudication in neuromyelitis optica spectrum disorder: Substantiation of criteria by magnetic resonance imaging and biomarkers in N-MOmentum
5. MOG-Enzephalomyelitis: Internationale Empfehlungen zu Diagnose und Antikörpertestung
6. Serum neurofilament light chain levels at attack predict post-attack disability worsening and are mitigated by inebilizumab: analysis of four potential biomarkers in neuromyelitis optica spectrum disorder
7. Temperature dependence of power handling capability of HTS filter with double-strip resonator
8. Effect of flow path structure on solid/liquid separation under electric field
9. MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
10. Artificial intelligence extension of the OSCAR-IB criteria
11. Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder
12. AQP4-IgG-seronegative patient outcomes in the N-MOmentum trial of inebilizumab in neuromyelitis optica spectrum disorder
13. Optic-spinal form of multiple sclerosis and immune-mediated myelopathy in Japan
14. Multiple sclerosis in Japan appears to be a milder disease compared to the UK
15. POSA8 Indirect Comparison Analysis of United States Food and Drug Administration-Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder
16. Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSD
17. Microfibril-associated protein 4 (MFAP4) as a biomarker for disease activity of optic neuritis associated-inflammatory demyelinating diseases
18. Long-term safety and efficacy of Eculizumab in Aquaporin-4 IgG-positive NMOSD
19. Spinal cord ring enhancement in patients with neuromyelitis optica
20. Myelin-oligodendrocyte glycoprotein antibody-associated disease
21. BENEFIT 8-year results provide further support for the long-term value of early treatment of multiple sclerosis
22. Role of sleep duration as a risk factor for Type 2 diabetes among adults of different ages in Japan: the Niigata Wellness Study
23. Association of treatment-achieved HbA1c with incidence of coronary artery disease and severe eye disease in diabetes patients
24. The impact of neuromyelitis optica spectrum disorder on pregnancy outcome: T203
25. Quantitative relationship between body weight gain in adulthood and incident type 2 diabetes: a meta-analysis
26. Preferential spinal central gray matter involvement in neuromyelitis optica: An MRI study
27. Intractable hiccup and nausea in neuromyelitis optica with anti-aquaporin-4 antibody: a herald of acute exacerbations
28. Two different clinical phenotypes of Creutzfeldt-Jakob disease with a M232R substitution
29. Epidemiology of neuromyelitis optica spectrum disorder and its prevalence and incidence worldwide
30. Impact of Eculizumab on Hospitalization Rates and Relapse Treatment in Patients With AQP4+NMOSD: the Phase 3 PREVENT Study
31. Impact of Eculizumab on Quality of Life in AQP4+NMOSD: Findings From the PREVENT Study
32. Influence of micro-structures on bending properties of braided laminated composites
33. Taste disorders in myasthenia gravis: a multicenter cooperative study
34. High normal HbA1c levels were associated with impaired insulin secretion without escalating insulin resistance in Japanese individuals: the Toranomon Hospital Health Management Center Study 8 (TOPICS 8)
35. Sequential changes of cholinergic and dopaminergic receptors in brains after 6-hydroxydopamine lesions of the medial forebrain bundle in rats
36. Flexural failure behavior of laminated composites reinforced with braided fabrics
37. Screening for pre-diabetes to predict future diabetes using various cut-off points for HbA1c and impaired fasting glucose: the Toranomon Hospital Health Management Center Study 4 (TOPICS 4)
38. Increases in [3H]FK-506 and [3H]L-NG-Nitro-Arginine Binding in the Rat Brain After Nigrostriatal Dopaminergic Denervation
39. Serum Neurofilament Light Chain Levels (sNfL) Correlate Best with Attack-related Disability in Neuromyelitis Optica (4105)
40. Long-term Efficacy and Safety of Inebilizumab for Neuromyelitis Optica Spectrum Disorder in the Randomized, Double-blind N-MOmentum Study and Extension (3998)
41. Influence of an SGLT2 inhibitor, tofogliflozin, on the resting heart rate in relation to adipose tissue insulin resistance
42. Efficacy of satralizumab in subgroups of patients in SAkuraSky: A phase III double-blind, placebo-controlled, add-on study in patients with neuromyelitis optica spectrum disorder (NMOSD)
43. Development of extensive brain lesions following interferon beta therapy in relapsing neuromyelitis optica and longitudinally extensive myelitis
44. Amplification of JC virus regulatory DNA sequences from cerebrospinal fluid: diagnostic value for progressive multifocal leukoencephalopathy
45. Marked increase in cerebrospinal fluid glial fibrillar acidic protein in neuromyelitis optica: an astrocytic damage marker
46. Stiffness and strength design of composite bone plates
47. Guided bone regeneration membrane made of polycaprolactone/calcium carbonate composite nano-fibers
48. Soluble CD26 and CD30 levels in CSF and sera of patients with relapsing neuromyelitis optica
49. Long-term safety and effectiveness of eculizumab in neuromyelitis optica spectrum disorder
50. Impact of eculizumab on disability measures in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: phase 3 PREVENT study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.